Mert Can Ataca

Dr. Mert Can Ataca


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2026 in Internal Medicine Journal
Verified
Journal Article
Closed access
EAEvrim Ataca
Evrim Ataca
MAMert Can Ataca
Mert Can Ataca
CHCihan Heybeli
Cihan Heybeli
LSLee Smith
Lee Smith
NVNicola Veronese
Nicola Veronese
PSPinar Soysal
Pinar Soysal

29 January 2026 in Egyptian Rheumatology and Rehabilitation
Verified
Journal Article
Open access
PDF file
MAMert Can Ataca
Mert Can Ataca
SGSemih Gülle
Semih Gülle
Background: Giant cell arteritis (GCA) is the most common large-vessel vasculitis in adults over 50 years of age and may rarely present with ischemic stroke. Its coexistence with premalignant or neoplastic lesions is increasingly recognized, with several studies reporting a temporal association between GCA and both solid and hematologic malignancies. We present a case highlighting the dual diagnostic role of 18 F-FDG PET/CT in detecting both GCA and an incidental colonic adenoma. Case presentation: A 70-year-old man was admitted with acute ischemic stroke presenting with amnesia and paraplegia. Brain MRI showed multiple bilateral small ischemic infarcts. Laboratory tests demonstrated elevated C-reactive protein and mild anemia. Thoracoabdominal CT indicated diffuse aortic wall thickening, and temporal artery ultrasound showed bilateral intima-media thickening. Whole-body PET/CT detected FDG uptake along the aorta and major branches, consistent with large-vessel vasculitis, and focal FDG uptake in the sigmoid colon wall without a corresponding CT lesion. Temporal artery biopsy confirmed GCA. The patient received high-dose corticosteroids followed by methotrexate and azathioprine. Colonoscopy, performed due to PET/CT findings, revealed a 3.5 cm villous adenoma with multifocal high-grade dysplasia, which was surgically resected. During five years of follow-up, no GCA relapse or malignant progression occurred. Conclusion: PET/CT provided a dual diagnostic benefit by confirming large-vessel GCA and identifying an unsuspected premalignant colonic lesion. This case illustrates the value of comprehensive imaging in elderly patients with systemic inflammation and stroke, while emphasizing the need for cautious interpretation and individualized management.

27 March 2026 in EULAR Rheumatology Open
Verified
Journal Article
Open access
MAMert Can Ataca
Mert Can Ataca
SGSemih Gulle
Semih Gulle

31 January 2026 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
EAEvrim Ataca
Evrim Ataca
MAMert Can Ataca
Mert Can Ataca
CHCihan Heybeli
Cihan Heybeli
Lee SmithLee Smith
Lee Smith
Nicola VeroneseNicola Veronese
Nicola Veronese
PSPinar Soysal
Pinar Soysal
Excessive daytime sleepiness (EDS) is common in older adults and may contribute to reduced oral intake, potentially increasing the risk of dehydration, whi

28 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MAMert Can Ataca
Mert Can Ataca
SGSemih Gülle
Semih Gülle
YEYesim Erez
Yesim Erez
EDErkan Derebek
Erkan Derebek
GSGercek Sen
Gercek Sen
Objective: To evaluate the diagnostic yield and clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with unexplained inflammation, fever, or suspected malignancy, and to assess its role across different rheumatologic subgroups. Methods: We retrospectively analyzed 280 patients who underwent PET/CT between 2010 and 2020 in a tertiary rheumatology center. Demographic, clinical, and laboratory data including erythrocyte sedimentation rate, C-reactive protein, and PET/CT indications were collected. PET/CT findings were categorized as inflammatory, neoplastic, or normal based on visual assessment and SUVmax. Final diagnoses were confirmed using clinical, histopathological, or follow-up data. Statistical analysis compared PET/CT results, inflammatory markers, and diagnostic outcomes among disease subgroups. Results: Of 280 patients (mean age 58 ± 15 years, 63.9% female), 72% had an established rheumatologic diagnosis prior to PET/CT. A new diagnosis, confirmed by predefined clinical, histopathological, or follow-up criteria, was established in 29.6% of patients, predominantly among those undergoing diagnostic evaluation for unexplained inflammation, including 40 rheumatologic and 43 non-rheumatologic conditions (22 malignancies). PET/CT led to therapeutic modification in 27.1% of all cases, based on multidisciplinary clinical decision-making. PET/CT demonstrated the highest diagnostic contribution in vasculitis, IgG4-related disease, and sarcoidosis. Median SUVmax was higher in malignancies than in inflammatory diseases [8.0 vs. 4.6, p < 0.05]. Lymphadenopathy was more frequent in non-rheumatologic and malignant conditions (p = 0.002). PET/CT findings showed variable but clinically relevant concordance with other imaging modalities. Conclusions: PET/CT provides supportive diagnostic and management insights in complex or atypical rheumatologic presentations. It demonstrated high yield in systemic inflammatory disorders and providing supportive information for malignancy exclusion in connective tissue diseases when interpreted alongside clinical and laboratory follow-up. Integration of PET/CT with clinical and laboratory data enhances diagnostic accuracy and supports patient-centered management in rheumatology.

3 July 2026 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
MAMert Can Ataca
Mert Can Ataca
SGSemih Gulle
Semih Gulle